chr1-152511821-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_178438.5(LCE5A):c.287C>A(p.Ser96Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000149 in 1,613,774 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_178438.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LCE5A | NM_178438.5 | c.287C>A | p.Ser96Tyr | missense_variant | 2/2 | ENST00000334269.3 | NP_848525.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LCE5A | ENST00000334269.3 | c.287C>A | p.Ser96Tyr | missense_variant | 2/2 | 3 | NM_178438.5 | ENSP00000333952.2 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152186Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000526 AC: 13AN: 247300Hom.: 0 AF XY: 0.0000223 AC XY: 3AN XY: 134690
GnomAD4 exome AF: 0.0000123 AC: 18AN: 1461470Hom.: 0 Cov.: 34 AF XY: 0.00000963 AC XY: 7AN XY: 727034
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152304Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74484
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 15, 2021 | The c.287C>A (p.S96Y) alteration is located in exon 2 (coding exon 1) of the LCE5A gene. This alteration results from a C to A substitution at nucleotide position 287, causing the serine (S) at amino acid position 96 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at